Clinical trial
A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of…
NCT00307814 · Ortho Biotech Products, L.P., Industry · Completed
Key facts
| NCT number | NCT00307814 |
|---|---|
| Title | A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) |
| Official title | A Randomized, Open-Label Clinical Evaluation of PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Renal Insufficiency |
| Intervention type | Drug |
| Interventions | Epoetin Alfa |
| Enrollment | 519 |
| Start date | Jan 1, 2002 |
| Completion | Jan 1, 2004 |
| First posted | Mar 28, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: